98 related articles for article (PubMed ID: 25075101)
1. Minichromosome maintenance protein 7 is a risk factor for recurrence in patients with Dukes C colorectal cancer.
Ishibashi Y; Kinugasa T; Akagi Y; Ohchi T; Gotanda Y; Tanaka N; Fujino S; Yuge K; Kibe S; Yoshida N; Mizobe T; Oka Y; Yoshida T; Shirouzu K
Anticancer Res; 2014 Aug; 34(8):4569-75. PubMed ID: 25075101
[TBL] [Abstract][Full Text] [Related]
2. Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance.
Nishihara K; Shomori K; Fujioka S; Tokuyasu N; Inaba A; Osaki M; Ogawa T; Ito H
Int J Oncol; 2008 Aug; 33(2):245-51. PubMed ID: 18636144
[TBL] [Abstract][Full Text] [Related]
3. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
[TBL] [Abstract][Full Text] [Related]
4. MCM7 expression is a promising predictor of recurrence in patients surgically resected for meningiomas.
Winther TL; Torp SH
J Neurooncol; 2017 Feb; 131(3):575-583. PubMed ID: 27868157
[TBL] [Abstract][Full Text] [Related]
5. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
Li SS; Xue WC; Khoo US; Ngan HY; Chan KY; Tam IY; Chiu PM; Ip PP; Tam KF; Cheung AN
Histopathology; 2005 Mar; 46(3):307-13. PubMed ID: 15720416
[TBL] [Abstract][Full Text] [Related]
6. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
[TBL] [Abstract][Full Text] [Related]
7. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
8. Ki-67 and minichromosome maintenance-7 (MCM7) expression in canine pituitary corticotroph adenomas.
Ishino H; Hara Y; Takekoshi S; Teshima T; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2011 Nov; 41(4):207-13. PubMed ID: 21982272
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of geminin in colorectal cancer: Implication of prognostic significance.
Nishihara K; Shomori K; Tamura T; Fujioka S; Ogawa T; Ito H
Oncol Rep; 2009 May; 21(5):1189-95. PubMed ID: 19360293
[TBL] [Abstract][Full Text] [Related]
10. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication.
Fujioka S; Shomori K; Nishihara K; Yamaga K; Nosaka K; Araki K; Haruki T; Taniguchi Y; Nakamura H; Ito H
Lung Cancer; 2009 Aug; 65(2):223-9. PubMed ID: 19144445
[TBL] [Abstract][Full Text] [Related]
11. DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer.
Padmanabhan V; Callas P; Philips G; Trainer TD; Beatty BG
J Clin Pathol; 2004 Oct; 57(10):1057-62. PubMed ID: 15452160
[TBL] [Abstract][Full Text] [Related]
12. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
13. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
[TBL] [Abstract][Full Text] [Related]
14. High minichromosome maintenance protein 7 proliferation indices: a powerful predictor of progression in pancreatic neuroendocrine neoplasms without distant metastasis at the time of surgery.
Ban X; Yan J; Yu S; Lu Z; Chang X; Jia C; Gao C; Shao H; Wu Y; Mao X; Zhang Y; Li Y; Chen J
Hum Pathol; 2019 Mar; 85():101-111. PubMed ID: 30447299
[TBL] [Abstract][Full Text] [Related]
15. [Determination of proliferative activity using Ki67 and expression of p53 in colorectal cancer].
Forones NM; Oshima C; Nanogaki S; Tanaka M; Barbosa V
Arq Gastroenterol; 1999; 36(3):122-6. PubMed ID: 10751898
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer.
Turan N; Benekli M; Koca D; Ustaalioglu BO; Dane F; Ozdemir N; Ulas A; Oztop I; Gumus M; Ozturk MA; Berk V; Kucukoner M; Uner A; Balakan O; Helvaci K; Ozkan S; Yilmaz U; Buyukberber S;
Oncology; 2013; 84(1):14-21. PubMed ID: 23076023
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of smoking in addition to established risk factors in patients with Dukes B and C colorectal cancer: a retrospective analysis.
Diamantis N; Xynos ID; Amptulah S; Karadima M; Skopelitis H; Tsavaris N
J BUON; 2013; 18(1):105-15. PubMed ID: 23613395
[TBL] [Abstract][Full Text] [Related]
19. [Multivariate analysis of prognostic factors in colorectal cancer patients with different ages].
Cai SR; Zheng S; Zhang SZ
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):483-5. PubMed ID: 16188146
[TBL] [Abstract][Full Text] [Related]
20. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.
Gonzalez MA; Pinder SE; Callagy G; Vowler SL; Morris LS; Bird K; Bell JA; Laskey RA; Coleman N
J Clin Oncol; 2003 Dec; 21(23):4306-13. PubMed ID: 14645419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
